Related Experiment Video
Updated: Apr 6, 2026

08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
17.4K
The complex liaison between cachexia and tumor burden (Review)
1Biomedical Research Division, Department of Theoretical and Applied Sciences, University of Insubria, Busto Arsizio, Varese, Italy.
Oncology Reports
|August 5, 2015
Summary
Measuring tumor burden alongside cachexia in cancer patients offers a better evaluation of this wasting syndrome. This approach helps assess individual patient vulnerability to cancer cachexia more accurately.
Area of Science:
- Oncology
- Pathology
- Host-pathogen interactions
Background:
- Cachexia is a significant wasting syndrome in end-stage cancer patients.
- A consensus definition for cachexia exists, but a reliable measurement is lacking.
- Tumor burden is a key factor in cachexia progression, but their relationship is variable.
Purpose of the Study:
- To discuss the utility of measuring tumor burden for improved cachexia evaluation.
- To explore the analogy between infectious disease tolerance and cancer cachexia.
- To assess inter-individual variation in host vulnerability to cancer cachexia.
Main Methods:
- Review of rodent model studies examining cachexia variation.
- Quantitative assessment comparing groups with different genotypes, treatments, diets, or genders.
- Survey of human malignancy studies on plotting cachexia estimates against tumor burden.
Main Results:
- Studies show varying relationships between cachexia severity and tumor burden.
- Some conditions reduce cachexia with lower tumor burden.
- Other conditions show cachexia inhibition independent of tumor burden, sometimes with increased cancer cell counts.
Conclusions:
- Measuring tumor burden can enhance the evaluation of cancer cachexia.
- This approach may reveal host vulnerability differences.
- It offers a novel perspective for both experimental and clinical oncology.
Related Concept Videos
The Tumor Microenvironment
8.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
Tumor Progression
7.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K
Tumor Progression
3.6K
3.6K
Adaptive Mechanisms in Cancer Cells
7.4K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Cancer Survival Analysis
838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Cancer
55.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.8K

